Convicted securities fraudster Martin Shkreli is facing fresh allegations that he and his company purposely and illegally inflated the price of the drug Daraprim, a life-saving medication used to prevent malaria and treat deadly diseases caused by foodborne illness.
Martin Shkreli, the cancer drug price-jacking pharmaceutical executive and convicted securities fraudster for whom the moniker “Pharma Bro” is among his politer nicknames, will be behind bars a little earlier than anticipated.